Comparison of CLL cells with SF3B1 mutation/del(13q) to CLL cells either with del(13q) or SF3B1 mutations revealed enrichment for mTORC1 pathway and BCR signaling associated with SF3B1 mutation but not del(13q) (Supplemental Figure 4C). This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.